On univariate analysis, CNPY2 overexpression was significantly associated with poor prognosis in 90 HCV+ HCC patients (hazard ratio (HR), 7.117; 95% confidence interval (CI), 0.971–52.18, p = 0.049). This evidence concerns the gene CNPY2 and hepatocellular carcinoma.